Tenofovir Disoproxil Fumarate to Treat Pediatric HIV

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2001

Study Completion Date

September 30, 2005

Conditions
HIV Infection
Interventions
DRUG

Tenofovir DF

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00024986 - Tenofovir Disoproxil Fumarate to Treat Pediatric HIV | Biotech Hunter | Biotech Hunter